IMP5 inhibitors are a class of chemical compounds that specifically target and inhibit the function of IMP5 (Importin-5), a member of the importin family of proteins involved in nucleocytoplasmic transport. Importins, including IMP5, play a critical role in the transport of proteins and other macromolecules between the cytoplasm and the nucleus, a process that is essential for the regulation of gene expression and various cellular processes. IMP5 is responsible for recognizing and binding specific cargo proteins that contain a nuclear localization signal (NLS) and facilitating their passage through the nuclear pore complex into the nucleus. Inhibitors of IMP5 disrupt this transport mechanism, preventing the proper localization of proteins that are crucial for nuclear functions.
Research involving IMP5 inhibitors has provided valuable insights into the regulation of nucleocytoplasmic transport and how it influences cellular processes such as cell cycle progression, stress responses, and signal transduction. By inhibiting IMP5, researchers can investigate the role of specific nuclear-imported proteins and how their mislocalization impacts gene regulation and other nuclear functions. This class of inhibitors allows scientists to study the specificity of IMP5's cargo recognition and its interaction with other importins and components of the nuclear pore complex. Additionally, IMP5 inhibitors serve as important tools for understanding how nucleocytoplasmic transport is dynamically regulated in response to various cellular conditions, such as changes in environmental stress or developmental cues. Through the use of these inhibitors, researchers can explore the complex mechanisms that govern the transport of macromolecules and how disruptions in this process can affect overall cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which could suppress the downstream signaling pathways that may activate IMP5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor, which can prevent the activation of AKT, potentially reducing the activation of IMP5 if it is downstream of AKT. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of a signaling pathway that can control protein synthesis and could regulate the translation of IMP5. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which functions upstream of ERK in the MAPK pathway; by inhibiting this pathway, the stabilization or activity of IMP5 could be affected. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which may alter the phosphorylation status of proteins that interact with or regulate IMP5. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, potentially altering stress response pathways that could influence IMP5 activity. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits AKT phosphorylation and activation, which could affect the signaling pathways regulating IMP5. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor that can also inhibit c-KIT, PDGFR, and BCR-ABL. By modulating these kinases, IMP5 activity or stability, if related to these pathways, can be affected. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR inhibitor, and by blocking EGFR signaling, it can influence downstream pathways that may include IMP5 regulation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor with activity against BCR-ABL, c-KIT, and PDGFR. If IMP5 is regulated by these kinases, its activity can be influenced by imatinib. | ||||||